Skip to Main Content

806

Views

0

CrossRef citations to date

0

Altmetric

Research Article

ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline

Tatsuto Hamatani1 Drug Development Division, Sumitomo Pharma Co., Ltd, Tokyo, Japan;2 Clinical Research, Sumitomo Pharma America, Inc, USACorrespondence[email protected]
View further author information

,

Naoki Atsuta3 Department of Neurology, Aichi Medical University School of Medicine, Nagakute, JapanView further author information

,

Fumiya Sano1 Drug Development Division, Sumitomo Pharma Co., Ltd, Tokyo, JapanView further author information

,

Ryoichi Nakamura3 Department of Neurology, Aichi Medical University School of Medicine, Nagakute, JapanView further author information

,

Yukikazu Hayashi4 Department of Business Development, A2 Healthcare Corporation, Tokyo, Japan, andView further author information

&

Gen Sobue5 Aichi Medical University School of Medicine, Nagakute, JapanView further author information